| Literature DB >> 27051278 |
Abstract
Graphene has attracted much attention of scientific community due to its enormous potential in different fields, including medical sciences, agriculture, food safety, cancer research, and tissue engineering. The potential for widespread human exposure raises safety concerns about graphene and its derivatives, referred to as graphene family nanomaterials (GFNs). Due to their unique chemical and physical properties, graphene and its derivatives have found important places in their respective application fields, yet they are being found to have cytotoxic and genotoxic effects too. Since the discovery of graphene, a number of researches are being conducted to find out the toxic potential of GFNs to different cell and animal models, finding their suitability for being used in new and varied innovative fields. This paper presents a systematic review of the research done on GFNs and gives an insight into the mode and action of these nanosized moieties. The paper also emphasizes on the recent and up-to-date developments in research on GFNs and their nanocomposites for their toxic effects.Entities:
Keywords: antibacterial; cytotoxicity; desalination; drug delivery; genotoxicity; graphene; quantum dots
Year: 2016 PMID: 27051278 PMCID: PMC4803243 DOI: 10.2147/NSA.S101818
Source DB: PubMed Journal: Nanotechnol Sci Appl ISSN: 1177-8903
Studies using GFNs or composites with respect to drug delivery systems
| Sr no | Authors | GFN or composite used | Purpose of use |
|---|---|---|---|
| 1. | Li et al | Pt(IV) conjugated nano-GO | To enhance the therapeutic efficacy of Pt drug |
| 2. | Wang et al | GQDs | Simultaneous targeted cellular imaging and drug delivery |
| 3. | Wang et al | Chlorotoxin-conjugated GO | Targeted delivery of an anticancer drug doxorubicin |
| 4. | Wang et al | Reduced GO-supported gold nanostars | Improved surface-enhanced Raman scattering sensing and drug delivery |
| 5. | Wang et al | Cyclic RGD-modified chitosan/GO polymers | Drug delivery and cellular imaging |
| 6. | Song et al | Hyaluronic acid-decorated GO nanohybrids | Targeted and pH-responsive anticancer drug delivery |
| 7. | Ou et al | Fe3O4/SiO2/graphene-CdTe QDs/chitosan nanocomposites | Targeted drug delivery |
| 8. | Liu et al | Polyamidoamine dendrimer and oleic acid-functionalized graphene | Biocompatible and efficient gene delivery vectors |
| 9. | Kim and Kim | rGO-polyethylenimine nanocomposite | Photothermally controlled gene delivery |
| 10. | You et al | Nano-GO | Cancer imaging and drug delivery |
| 11. | Rahmanian et al | Nano-GO | Oral delivery of flavonoids |
| 12. | Liu et al | Starch-functionalized graphene | pH-sensitive and starch-mediated drug delivery |
| 13. | Yang et al | GO/manganese ferrite nanohybrids | Magnetic resonance imaging, photothermal therapy, and drug delivery |
| 14. | Wu et al | Peptide–GO hybrid hydrogel | Drug delivery and pulsatile triggered release in vivo |
| 15. | Tang et al | GO-wrapped mesoporous silica nanoparticles | An aptamer-targeting photoresponsive drug delivery system |
| 16. | Mo et al | DNA–graphene hybrid nanoaggregates | Anticancer drug delivery doxorubicin |
| 17. | Chen et al | PEGylated GO | Photothermally controlled drug delivery |
| 18. | Song et al | PEGylated GO | Sequential delivery of lidocaine and thalidomide drugs |
| 19. | Xu et al | PEGylated GO | Delivery of paclitaxel |
| 20. | Mianehrow et al | GO stabilized in electrolyte solutions using hydroxyethyl cellulose | Drug delivery |
Abbreviations: CdTe, cadmium telluride; GFNs, graphene family nanomaterials; GO, graphene oxide; QD, quantum dot; GQDs, graphene quantum dots; rGO, reduced graphene oxide; Sr no, serial number.
Figure 1Possible mechanism of bacterial cell death with reduced GONW.
Abbreviations: GONW, graphene oxide nanowall; rGONW, reduced graphene oxide nanowall.
Comparative analysis of cytotoxicity of GFNs
| Sr no | Authors | Study material | Results |
|---|---|---|---|
| 1. | Ali-Boucetta et al | Purified GO dispersions | Purified GO did not induce significant cytotoxic responses |
| 2. | Cai et al | Sodium 1-naphthalenesulfonate-functionalized rGO | Low cytotoxicity and long-term antibacterial activity |
| 3. | Du et al | PEGylated GO on lymphoma cells | PEG-GO had excellent dispersion and low toxicity on lymphoma cells |
| 4. | Lammel et al | GO and carboxyl graphene nanoplatelets in the human hepatocellular carcinoma cell line HepG2 | Dose- and time-dependent cytotoxicity in HepG2 cells; plasma membrane damage and induction of oxidative stress. No toxicity at low concentrations (<4 µg/mL) |
| 5. | Li et al | GO/gold nanocomposites | Nanocomposites can significantly reduce the cytotoxicity of the amyloid peptides |
| 6. | Liao et al | GO and graphene in human erythrocytes and skin fibroblasts | Graphene sheets are more damaging to mammalian fibroblasts than GO. GO showed higher hemolytic activity than graphene sheets. Coating GO with chitosan nearly eliminated hemolytic activity |
| 7. | Qu et al | QDs and GO to erythroid cells and macrophages | QDs coupled with ROS are highly damaging to macrophages, particularly QDs coated with PEG-NH2. GO could provoke apoptosis of erythroid cells |
| 8. | Wang et al | GO on human lung fibroblast cells | Surface charge on GO plays an important role in its toxicity to HLF cells |
| 9. | Wu et al | GO on human MDA-MB-231 cells | Higher GO concentrations increased G0/G1phase cell proportion; induced LDH release and intracellular ROS production |
| 10. | Wu et al | GO and GO loaded with doxorubicin | GO caused low cytotoxicity and did not induce cell apoptosis or change the cell cycle in multiple myeloma cells |
| 11. | Yuan et al | Oxidized SWCNTs and GO on human hepatoma HepG2 cells | Oxidized SWCNTs induced oxidative stress; interfered with intracellular metabolic routes, protein synthesis and cytoskeletal systems; perturbed the cell cycle and significant increase in the proportion of apoptotic cells |
| 12. | Zhang et al | Uniform ultrasmall GO nanosheets | Excellent biocompatibility; lower cytotoxicity, and higher cellular uptake |
| 13. | Zhang et al | GO | GO reduced Vpr13-33-induced cytotoxicity to neuroblastoma cells and T-cells |
Abbreviations: GFNs, graphene family nanomaterials; GO, graphene oxide; HLF, human lung fibroblast; LDH, lactate dehydrogenase; QD, quantum dot; rGO, reduced graphene oxide; ROS, reactive oxygen species; SWCNTs, single-walled carbon nanotubes; Sr no, serial number.